Outcomes by histology and prior therapy with lenvatinib plus pembrolizumab vs treatment of physician's choice in patients with advanced endometrial cancer (Study 309/KEYNOTE-775)

被引:16
作者
Colombo, N. [1 ]
Lorusso, D. [2 ]
Casado Herraez, A. [3 ]
Santin, A. D. [4 ]
Colomba, E. [5 ]
Miller, D. S. [6 ]
Fujiwara, K. [7 ]
Pignata, S. [8 ]
Floquet, A. [9 ]
Monk, B. J. [10 ]
Banerjee, S. [11 ]
Penson, R. T. [12 ]
Kristeleit, R. [13 ]
Fabbro, M. [14 ]
Orlando, M. [15 ]
Mackay, H. [16 ]
Jensen, E. [17 ]
Dutta, L. [18 ]
Orlowski, R. [17 ]
Makker, V. [19 ]
机构
[1] Univ Milano Bicocca, European Inst Oncol, IRCCS, Dept Gynecol Oncol, Milan, Italy
[2] Fdn Policlin Univ Agostino Gemelli, Gynaecol Oncol Unit, IRCCS, Rome, Italy
[3] San Carlos Univ, Dept Med Oncol, Teaching Hosp, Madrid, Spain
[4] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA
[5] Gustave Roussy Cancerol Inst, GINECO Grp, Dept Canc Med, Villejuif, France
[6] Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX 75390 USA
[7] Saitama Med Univ, Int Med Ctr, Hidaka, Japan
[8] Ist Nazl Tumori IRCCS Fdn G Pascale, Dept Uro Gynecol, Naples, Italy
[9] Inst Bergonie, Dept Med Oncol Gynecol Tumors, Bordeaux, France
[10] Arizona Oncol, Dept Obstet & Gynecol, Div Gynecol Oncol, Phoenix, AZ USA
[11] Royal Marsden NHS Fdn Trust, Gynaecol Unit, London, England
[12] Massachusetts Gen Hosp, Med Gynecol Oncol, Boston, MA 02114 USA
[13] Guys & St Thomas NHS Fdn Trust, Dept Oncol, London, England
[14] Inst Canc Montpellier, Dept Med Oncol, Montpellier, France
[15] Inst Alexander Fleming, Dept Oncol, Buenos Aires, DF, Argentina
[16] Univ Toronto, Div Med Oncol & Hematol, Toronto, ON, Canada
[17] Merck & Co Inc, Oncol, Kenilworth, NJ USA
[18] Eisai Inc, Oncol, Woodcliff, NJ USA
[19] Mem Sloan Kettering Canc Ctr, Med Oncol, 1275 York Ave, New York, NY 10021 USA
关键词
D O I
10.1016/j.annonc.2021.08.1169
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
726MO
引用
收藏
页码:S729 / S730
页数:2
相关论文
empty
未找到相关数据